500
Participants
Start Date
January 15, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2028
Home Lab
The main goal is to comprehensively assess the cognitive and behavioral status of all participants, regardless of their assigned groups. Validated clinical tests (considered the gold standard) will be used, with measurements taken at participants' homes using a biosignal monitoring kit-the focal tool of the project. Whether in the control or specific groups, all participants will undergo an identical battery of tests in both the laboratory and home settings. The study design includes an introductory session for participants to understand the study's purpose and sign informed consent. Following consent, participants will have three sessions within a 3 to 6-week timeframe: one for autonomous technology use instruction and the other two for cognitive and functional evaluations.
RECRUITING
Bitbrain, Zaragoza
Lead Sponsor
Hospital Miguel Servet
OTHER
Hospital Provincial Nuestra Señora de Gracia
UNKNOWN
Hospital Clínico Zaragoza
UNKNOWN
Universidad de Zaragoza
OTHER
Instituto de Investigación Sanitaria de Aragón
UNKNOWN
Bitbrain
INDUSTRY